Veterinary Medicines

Bovilis Ringvac <9 and >21 Lyophilisate+solvent for suspension for injection

Authorised
  • Trichophyton verrucosum, strain LTF-130, Live
Download as PDF

Product identification

Medicine name:
BOVILIS RINGVAC >=9x10^6 AND <=21x10^6 ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Bovilis Ringvac <9 and >21 Lyophilisate+solvent for suspension for injection
Active substance:
  • Trichophyton verrucosum, strain LTF-130, Live
Target species:
  • Cattle
  • Cattle (calf)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Trichophyton verrucosum, strain LTF-130, Live
    21000000.00
    cells
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AP01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • (ID2) 40 millilitre(s); 40 Dose: Box (Cardboard) with 1 Bottle (Glass) with 40 Dose and 1 Bottle (Glass) with 40 millilitre(s)
  • (ID1) 10 Dose; 10 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 10 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 61369/17-09-2015/K-0156201
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0231/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • France
  • Greece
  • Hungary
  • Ireland
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Slovenia